Prandial Metabolic Phenotyping in Sarcopenic Older Adults Comparing Plant Based and Whey Based Protein

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-95
SponsorTexas A&M University

About this trial

The researchers overall objective is to determine whether plant and animal protein based proteins affect the anabolic responses across aging populations differently due to specific changes in the essential amino acids (EAA) and non-essential amino acids (NEAA) kinetic responses. The researchers central hypothesis is that a high EAA to NEAA ratio in a protein meal is related to higher anabolic response to the meal. The researchers also hypothesize that the type of NEAA in a protein meal also affects the anabolic capacity of the meal. The researchers rationale is that finding the amino acid composition of a meal that will maximally induce protein anabolism will guide novel nutritional approaches to prevent and treat sarcopenia, thereby reducing both overall economic burden and improving individual patient outcomes.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age 50-95 years old

Diagnosis of Chronic Obstructive Pulmonary Disease (COPD); COPD group only

Stable body-weight (±5%) for the past 3 months

Ability to walk, sit down, and stand up (independently or with walking assistance device)

Disqualifiers

Established diagnosis and active treatment of chronic disease: Insulin dependent diabetes mellitus, active malignancy, heart disease, kidney disease, liver disease, HIV/AIDS, Asthma (moderate to severe), Hep (A,B, or C)

History of untreated metabolic disease including hepatic or renal disorder

Presence of acute illness or metabolically unstable chronic illness

Hysterectomy

Trial design

Design model

Crossover

Treatments tested in this trial

  • Whey Protein Isolate 90%

    Dietary supplement

    Commercially available animal based protein powders

  • Soy Protein Isolate (90% Protein)

    Dietary supplement

    Commercially available plant based protein powders

  • Organic Pea Protein Isolate

    Dietary supplement

    Commercially available plant based protein powders

  • Placebo (Water)

    Dietary supplement

    Normal drinking water

Treatment groups

100 Participants
are divided into 8 treatment groups

8

Treatment groups

See each treatment group below.

Group A: Healthy male older adultsExperimental treatment 4 interventions
Group B: Healthy female older adultsExperimental treatment 4 interventions
Group C: Healthy male old older adultsExperimental treatment 4 interventions
Group D: Healthy female old older adultsExperimental treatment 4 interventions
Group E: Sarcopenic male old older adultsExperimental treatment 4 interventions
Group F: Sarcopenic female old older adultsExperimental treatment 4 interventions
Group G: COPD male older adultsExperimental treatment 4 interventions
Group H: COPD female older adultsExperimental treatment 4 interventions

Trial outcomes

Primary outcomes

1

Protein and amino acid synthesis capacity of plant-based and animal-based protein in older adults with or without sarcopenia measured by the use of stable isotope tracers

A novel stable isotope technique will be used to assess simultaneously the anabolic response and whole body production rates of a variety of amino acids to intake of both dietary proteins in sarcopenic older participants. The samples will be stored in laboratory freezers and the amino acid isotope enrichments and concentrations analyzed by Liquid Chromatography with tandem mass spectrometry (LC-MS/MS). The researchers will then conduct LC-MS/MS analysis, peak integration, calculation of amino acid concentrations and whole body productions from raw data, and use the results for preparation of papers for presentation, publication, and final reports. The researchers main hypothesis is that plant-based protein induces less protein anabolism, due to lower whole body production of essential amino acids (EAA) and higher production of non-essential amino acids (NEAA) as compared to dairy protein.

Time frame
4 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.